These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
746 related items for PubMed ID: 23932644
21. Obesity-dependent cannabinoid modulation of proliferation in adult neurogenic regions. Rivera P, Romero-Zerbo Y, Pavón FJ, Serrano A, López-Ávalos MD, Cifuentes M, Grondona JM, Bermúdez-Silva FJ, Fernández-Llebrez P, de Fonseca FR, Suárez J, Pérez-Martín M. Eur J Neurosci; 2011 May; 33(9):1577-86. PubMed ID: 21395869 [Abstract] [Full Text] [Related]
29. Acute anorectic response to cannabinoid CB1 receptor antagonist/inverse agonist AM 251 in rats: indirect behavioural mediation. Tallett AJ, Blundell JE, Rodgers JR. Behav Pharmacol; 2007 Nov; 18(7):591-600. PubMed ID: 17912043 [Abstract] [Full Text] [Related]
30. Combined stimulation of glucagon-like peptide-1 receptor and inhibition of cannabinoid CB1 receptor act synergistically to reduce food intake and body weight in the rat. Bojanowska E, Radziszewska E. J Physiol Pharmacol; 2011 Aug; 62(4):395-402. PubMed ID: 22100840 [Abstract] [Full Text] [Related]
31. Cannabinoid-1 receptor inhibition prevents the reduction of 24-hour energy expenditure with weight loss. Strack AM, Nicolich S, Faidley T, Achanfuo-Yeboah J, Cunningham PK, Hora D, Thompson D, Hickey G, Johnson-Levonas AO, Fong TM, Heymsfield SB. Metabolism; 2012 Apr; 61(4):546-53. PubMed ID: 22001334 [Abstract] [Full Text] [Related]
32. The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant's antiobesity effects in mice. Pang Z, Wu NN, Zhao W, Chain DC, Schaffer E, Zhang X, Yamdagni P, Palejwala VA, Fan C, Favara SG, Dressler HM, Economides KD, Weinstock D, Cavallo JS, Naimi S, Galzin AM, Guillot E, Pruniaux MP, Tocci MJ, Polites HG. Obesity (Silver Spring); 2011 Oct; 19(10):1923-34. PubMed ID: 21799481 [Abstract] [Full Text] [Related]
33. Cannabinoid CB1 receptor inverse agonist MJ08 stimulates glucose production via hepatic sympathetic innervation in rats. Chen W, Liu H, Guan H, Xue N, Wang L. Eur J Pharmacol; 2017 Nov 05; 814():232-239. PubMed ID: 28844874 [Abstract] [Full Text] [Related]
39. Treatment with a novel oleic-acid-dihydroxyamphetamine conjugation ameliorates non-alcoholic fatty liver disease in obese Zucker rats. Decara JM, Pavón FJ, Suárez J, Romero-Cuevas M, Baixeras E, Vázquez M, Rivera P, Gavito AL, Almeida B, Joglar J, de la Torre R, Rodríguez de Fonseca F, Serrano A. Dis Model Mech; 2015 Oct 01; 8(10):1213-25. PubMed ID: 26438694 [Abstract] [Full Text] [Related]
40. Effect of phenylpiperidine opioid antagonists on food consumption and weight gain of the obese Zucker rat. Shaw WN, Mitch CH, Leander JD, Zimmerman DM. J Pharmacol Exp Ther; 1990 Apr 01; 253(1):85-9. PubMed ID: 2329525 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]